ADC Therapeutics SA (ADCT)
1.105
+0.13
(+13.02%)
USD |
NYSE |
Jun 09, 16:00
1.07
-0.04
(-3.17%)
After-Hours: 20:00
ADC Therapeutics Research and Development Expense (Quarterly) : 19.88M for March 31, 2026
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| BeOne Medicines Ltd. | 521.31M |
| AC Immune SA | 14.99M |
| CRISPR Therapeutics AG | 66.37M |
| Idorsia Ltd. | 33.91M |
| MoonLake Immunotherapeutics | 53.67M |